PureTech Health (PRTC) Short-term Investments (2019 - 2025)
PureTech Health (PRTC) reported Short-term Investments of $59.3 million for Q2 2025, down 69.1% year-over-year from $191.9 million in Q2 2024, and down 31.57% quarter-over-quarter from $86.7 million in Q4 2024.
PureTech Health (PRTC) Short-term Investments (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 5 years of Short-term Investments data on file, last reported at $59.3 million in Q2 2025.
- Short-term Investments for Q2 2025 came in at $59.3 million, down 69.1% year-over-year; the trailing twelve-month figure through Jun 2025 was $59.3 million (down 69.1% YoY), and the FY2024 annual result was $86.7 million, down 36.3% from the prior year.
- Short-term Investments fell to $59.3 million in Q2 2025 per PRTC's latest filing, from $86.7 million in the prior quarter.
- Over five years, Short-term Investments peaked at $200.2 million in Q4 2022 and troughed at $59.3 million in Q2 2025.
- A 4-year average of $134.8 million and a median of $136.1 million in 2023 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2023 and 2025: Short-term Investments slumped 32.04% in 2023, then sank 69.1% in 2025.
- A 4-year view of Short-term Investments shows it stood at $200.2 million in 2022, then tumbled by 32.04% to $136.1 million in 2023, then sank by 36.3% to $86.7 million in 2024, then tumbled by 31.57% to $59.3 million in 2025.
- Business Quant data shows PRTC's Short-term Investments at $59.3 million in Q2 2025, $86.7 million in Q4 2024, and $191.9 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 59.30 Mn |
| Dec 31, 2024 | 86.67 Mn |
| Jun 30, 2024 | 191.94 Mn |
| Dec 31, 2023 | 136.06 Mn |
| Dec 31, 2022 | 200.20 Mn |
| Dec 31, 2019 | 30.09 Mn |